全文获取类型
收费全文 | 3905篇 |
免费 | 280篇 |
国内免费 | 19篇 |
专业分类
耳鼻咽喉 | 49篇 |
儿科学 | 152篇 |
妇产科学 | 90篇 |
基础医学 | 486篇 |
口腔科学 | 140篇 |
临床医学 | 320篇 |
内科学 | 797篇 |
皮肤病学 | 69篇 |
神经病学 | 246篇 |
特种医学 | 141篇 |
外科学 | 572篇 |
综合类 | 51篇 |
一般理论 | 2篇 |
预防医学 | 313篇 |
眼科学 | 143篇 |
药学 | 391篇 |
中国医学 | 17篇 |
肿瘤学 | 225篇 |
出版年
2023年 | 53篇 |
2022年 | 100篇 |
2021年 | 155篇 |
2020年 | 122篇 |
2019年 | 162篇 |
2018年 | 210篇 |
2017年 | 98篇 |
2016年 | 127篇 |
2015年 | 103篇 |
2014年 | 169篇 |
2013年 | 206篇 |
2012年 | 285篇 |
2011年 | 258篇 |
2010年 | 163篇 |
2009年 | 111篇 |
2008年 | 185篇 |
2007年 | 152篇 |
2006年 | 155篇 |
2005年 | 152篇 |
2004年 | 128篇 |
2003年 | 140篇 |
2002年 | 108篇 |
2001年 | 75篇 |
2000年 | 55篇 |
1999年 | 63篇 |
1998年 | 23篇 |
1997年 | 27篇 |
1996年 | 16篇 |
1995年 | 27篇 |
1994年 | 18篇 |
1993年 | 17篇 |
1992年 | 41篇 |
1991年 | 32篇 |
1990年 | 26篇 |
1989年 | 35篇 |
1988年 | 30篇 |
1987年 | 28篇 |
1986年 | 16篇 |
1985年 | 32篇 |
1984年 | 14篇 |
1983年 | 17篇 |
1982年 | 24篇 |
1981年 | 26篇 |
1980年 | 16篇 |
1979年 | 18篇 |
1978年 | 21篇 |
1977年 | 20篇 |
1973年 | 17篇 |
1971年 | 17篇 |
1970年 | 13篇 |
排序方式: 共有4204条查询结果,搜索用时 31 毫秒
101.
102.
103.
Muhammad?M.?HammamiEmail author Eman?Al Gaai Safa?Hammami Sahar?Attala 《BMC palliative care》2015,14(1):66
Background
Quality end-of-life care depends on understanding patients’ end-of-life choices. Individuals and cultures may hold end-of-life priorities at different hierarchy. Forced ranking rather than independent rating, and by-person factor analysis rather than averaging may reveal otherwise masked typologies.Methods
We explored Saudi males’ forced-ranked, end-of-life priorities and dis-priorities. Respondents (n?=?120) rank-ordered 47 opinion statements on end-of-life care following a 9-category symmetrical distribution. Statements’ scores were analyzed by averaging analysis and factor analysis (Q-methodology).Results
Respondents’ mean age was 32.1 years (range, 18–65); 52 % reported average religiosity, 88 and 83 %?≥?very good health and life-quality, respectively, and 100 %?≥?high school education. Averaging analysis revealed that the extreme five end-of-life priorities were to, be at peace with God, be able to say the statement of faith, maintain dignity, resolve conflicts, and have religious death rituals respected, respectively. The extreme five dis-priorities were to, die in the hospital, not receive intensive care if in coma, die at peak of life, be informed about impending death by family/friends rather than doctor, and keep medical status confidential from family/friends, respectively. Q-methodology classified 67 % of respondents into five highly transcendent opinion types. Type-I (rituals-averse, family-caring, monitoring-coping, life-quality-concerned) and Type-V (rituals-apt, family-centered, neutral-coping, life-quantity-concerned) reported the lowest and highest religiosity, respectively. Type-II (rituals-apt, family-dependent, monitoring-coping, life-quantity-concerned) and Type-III (rituals-silent, self/family-neutral, avoidance-coping, life-quality & quantity-concerned) reported the best and worst life-quality, respectively. Type-I respondents were the oldest with the lowest general health, in contrast to Type-IV (rituals-apt, self-centered, monitoring-coping, life-quality/quantity-neutral). Of the extreme 14 priorities/dis-priorities for the five types, 29, 14, 14, 50, and 36 %, respectively, were not among the extreme 20 priorities/dis-priorities identified by averaging analysis for the entire cohort.Conclusions
1) Transcendence was the extreme end-of-life priority, and dying in the hospital was the extreme dis-priority. 2) Quality of life was conceptualized differently with less emphasize on its physiological aspects. 3) Disclosure of terminal illness to family/close friends was preferred as long it is through the patient. 4) Q-methodology identified five types of constellations of end-of-life priorities and dis-priorities that may be related to respondents’ demographics and are partially masked by averaging analysis.104.
105.
Mohamed F. Abdel Rahman Ingy M. Hashad Khaled Abou-Aisha Sahar M. Abdel-Maksoud Mohamed Z. Gad 《Archives of Medical Science》2015,11(3):513-520
Introduction
The enzyme paraoxonase-1 (PON1) represents an endogenous defense mechanism against vascular oxidative stress, thereby contributing to the prevention of atherosclerosis. Several polymorphisms have been reported in the PON1 gene, including Q192R. PON1 phenotype is commonly expressed as the paraoxonase/arylesterase ratio (PON/ARE). The major aim of this study was to investigate the association between PON1 Q192R polymorphism, PON1 phenotypes and the incidence of early-onset acute myocardial infarction (AMI) in Egyptians.Material and methods
The study subjects consisted of 102 AMI patients and 72 age-matched healthy controls. Genotyping and enzyme activities were determined using PCR-RFLP and kinetic spectrophotometric assays, respectively.Results
The genotype distribution for the PON1 gene was significantly different between AMI patients (QQ = 38.24%, QR = 49.02%, RR = 12.75%) and controls (QQ = 66.67%, QR = 25%, RR = 8.33%). Allele frequencies were also significantly different between patients (Q = 62.75%, R = 37.25%) and controls (Q = 79.17%, R = 20.83%). The genotypes QR and RR showed higher risk for AMI compared to the homozygous QQ (odds ratio (OR) = 3.231, p < 0.001). The average PON/ARE ratio in MI patients (1.187 ±0.1) did not differ significantly from controls (1.118 ±0.26). However, it showed a significant difference among different genotypes in both AMI patients (QQ = 0.91 ±0.11, QR = 1.09 ±0.11 and RR = 2.65 ±0.4) (p = 0.0002) and controls (QQ = 0.68 ±0.1, QR = 1.07 ±0.11 and RR = 4.89 ±2.84) (p < 0.0001).Conclusions
PON1 192R allele represents an independent risk factor for early-onset AMI in Egyptians, and PON1 Q192R polymorphism modulates the paraoxonase phenotype. 相似文献106.
Kevan C. Herold Sahar Usmani-Brown Tara Ghazi Jasmin Lebastchi Craig A. Beam Melena D. Bellin Michel Ledizet Jay M. Sosenko Jeffrey P. Krischer Jerry P. Palmer the Type Diabetes TrialNet Study Group 《The Journal of clinical investigation》2015,125(3):1163-1173
Role of the funding source: Funding from the NIH was used for support of the participating clinical centers and the coordinating center. The funding source did not participate in the collection or the analysis of the data.BACKGROUND. The β cell killing that characterizes type 1 diabetes (T1D) is thought to begin years before patients present clinically with metabolic decompensation; however, this primary pathologic process of the disease has not been measured.METHODS. Here, we measured β cell death with an assay that detects β cell–derived unmethylated insulin (INS) DNA. Using this assay, we performed an observational study of 50 participants from 2 cohorts at risk for developing T1D from the TrialNet Pathway to Prevention study and of 4 subjects who received islet autotransplants.RESULTS. In at-risk subjects, those who progressed to T1D had average levels of unmethylated INS DNA that were elevated modestly compared with those of healthy control subjects. In at-risk individuals that progressed to T1D, the observed increases in unmethylated INS DNA were associated with decreases in insulin secretion, indicating that the changes in unmethylated INS DNA are indicative of β cell killing. Subjects at high risk for T1D had levels of unmethylated INS DNA that were higher than those of healthy controls and higher than the levels of unmethylated INS DNA in the at-risk progressor and at-risk nonprogressor groups followed for 4 years. Evaluation of insulin secretory kinetics also distinguished high-risk subjects who progressed to overt disease from those who did not.CONCLUSION. We conclude that a blood test that measures unmethylated INS DNA serves as a marker of active β cell killing as the result of T1D-associated autoimmunity. Together, the data support the concept that β cell killing occurs sporadically during the years prior to diagnosis of T1D and is more intense in the peridiagnosis period.TRIAL REGISTRATION. Clinicaltrials.gov .FUNDING. Funding was from the NIH, the Juvenile Diabetes Research Foundation, and the American Diabetes Association. NCT00097292相似文献
107.
108.
Mohammed AlSheef Mastourah Alotaibi Abdul Rehman Z. Zaidi Areej Alshamrani Aroub Alhamidi Syed Ziauddin A. Zaidi Noor Alanazi Sarah Alhathlool Ohoud Alarfaj Mohammed AlHazzaa Ghaydaa Kullab Amany Alboghdadly Amani Abu-Shaheen 《Saudi medical journal》2020,41(10):1063
Objectives:To identify the epidemiologic profile of cerebral vein thrombosis (CVT) among fasting women using oral contraceptive pills (OCPs) during the holy month of Ramadan.Methods:This retrospective study was conducted on all patients diagnosed with CVT and using OCPs from records at a tertiary care hospital in Riyadh, Saudi Arabia during 2016-2017. The study participants were categorized into 2 groups (an intermittently fasting group during the holy month of Ramadan and a non-fasting group).Results:Out of 108 female patients with CVT, 36.1% were secondary to OCP, of whom 41% participants were fasting. The most affected site was the transverse sinus. Holocephalic headache was more common amongst fasting group (68.8%) compared to non-fasting group (30.4%) (p=0.025). Dehydration (p=0.003) amongst the fasting group and protein S deficiency (p=0.027) in the non-fasting group were identified as the 2 prominent risk factors. Unfractionated heparin was the most common anticoagulant therapies used during the initiation phase for non-fasting (36.4%) and fasting groups (50%).Conclusion:All women who are using OCP should undergo formal written risk assessments for factors of CVT. Our study suggests that the negative effects of OCPs use might outweigh its benefits; thus, it should be prescribed with caution, more so in fasting patients. 相似文献
109.
Lorcan P. McGarvey Claire A. Butler Susan Stokesberry Liam Polley Stephen McQuaid Hani’ah Abdullah Sadaf Ashraf Mary K. McGahon Tim M. Curtis Joe Arron David Choy Tim J. Warke Peter Bradding Madeleine Ennis Alexander Zholos Richard W. Costello Liam G. Heaney 《The Journal of allergy and clinical immunology》2014
110.
Gabriela E Jones Pia Ostergaard Anthony T Moore Fiona C Connell Denise Williams Oliver Quarrell Angela F Brady Isabel Spier Filiz Hazan Oana Moldovan Dagmar Wieczorek Barbara Mikat Florence Petit Christine Coubes Robert A Saul Glen Brice Kristiana Gordon Steve Jeffery Peter S Mortimer Pradeep C Vasudevan Sahar Mansour 《European journal of human genetics : EJHG》2014,22(7):881-887
Microcephaly with or without chorioretinopathy, lymphoedema, or mental retardation (MCLMR) (MIM No.152950) is a rare autosomal dominant condition for which a causative gene has recently been identified. Mutations in the kinesin family member 11 (KIF11) gene have now been described in 16 families worldwide. This is a review of the condition based on the clinical features of 37 individuals from 22 families. This report includes nine previously unreported families and additional information for some of those reported previously. The condition arose de novo in 8/20 families (40%). The parental results were not available for two probands. The mutations were varied and include missense, nonsense, frameshift, and splice site and are distributed evenly throughout the KIF11 gene. In our cohort, 86% had microcephaly, 78% had an ocular abnormality consistent with the diagnosis, 46% had lymphoedema, 73% had mild-moderate learning difficulties, 8% had epilepsy, and 8% had a cardiac anomaly. We identified three individuals with KIF11 mutations but no clinical features of MCLMR demonstrating reduced penetrance. The variable expression of the phenotype and the presence of mildly affected individuals indicates that the prevalence may be higher than expected, and we would therefore recommend a low threshold for genetic testing. 相似文献